Department of Surgical Disciplines, All India Institute of Medical Sciences, New Delhi, India.
Surg Laparosc Endosc Percutan Tech. 2023 Oct 1;33(5):435-439. doi: 10.1097/SLE.0000000000001216.
Hiatal hernia (HH), whenever encountered during sleeve gastrectomy (SG), needs to be addressed because of its strong association with gastroesophageal reflux disease (GERD). However, the mid-term to long-term effects of hiatal hernia repair (HHR) on GERD remain unclear.
This was a cross-sectional observational analysis of patients who underwent SG + HHR and had completed at least 1 year of follow-up. The preoperative data were retrieved from a prospectively maintained database. Of the 590 patients who underwent SG, 63 patients (10.7%) with concomitant HHR were assessed for the use of proton pump inhibitors (PPIs) and symptoms of GERD using the GERD-Q questionnaire.
Of the 63 patients, 11 were lost to follow-up, and one underwent Roux-en-Y gastric bypass for HH recurrence and severe reflux. The remaining 51 patients were assessed at a mean follow-up of 3.7±2.0 years. Of these, 51% (26/51) patients had preoperative reflux symptoms. On follow-up, 69.2% (18/26) had complete resolution with significant improvement in their GERD-Q scores (9.8±3.1 to 6.5±2.1; P =0.001), while 76.2% (16/21) of patients were off the PPIs. The incidence of de novo GERD was found in 20% (5/25) of the patients.
In patients of morbid obesity with HH, concomitant HHR with SG leads to improvement of the reflux symptoms in more than two-thirds of the patients, besides alleviating the use of PPIs.
在袖状胃切除术(SG)中遇到食管裂孔疝(HH)时,由于其与胃食管反流病(GERD)密切相关,需要进行处理。然而,HH 修复(HHR)对 GERD 的中期至长期影响仍不清楚。
这是一项对接受 SG+HHR 且至少完成 1 年随访的患者进行的横断面观察性分析。术前数据从一个前瞻性维护的数据库中检索。在接受 SG 的 590 例患者中,有 63 例(10.7%)伴有 HH 的患者使用质子泵抑制剂(PPIs)和 GERD-Q 问卷评估 GERD 的症状。
在这 63 例患者中,有 11 例失访,1 例因 HH 复发和严重反流而行 Roux-en-Y 胃旁路术。其余 51 例患者平均随访 3.7±2.0 年。其中,51%(26/51)的患者有术前反流症状。在随访中,69.2%(18/26)的患者完全缓解,GERD-Q 评分显著改善(9.8±3.1 至 6.5±2.1;P=0.001),同时 76.2%(16/21)的患者停用了 PPI。新发 GERD 的发生率为 20%(5/25)。
在肥胖伴 HH 的患者中,SG 联合 HHR 可使三分之二以上的患者的反流症状得到改善,同时减轻 PPI 的使用。